Hints and tips:
...“This is another example of a new wave of highly-targeted treatments, which deliver anticancer drugs even more precisely to where they are needed,” said Dr Gregory Masters, an oncologist at the Helen F Graham...
...Robert M Hoffman Professor of Surgery, University of California, San Diego, US President, AntiCancer Inc...
...Hoffman, Professor of Surgery, University of California, San Diego, CA, US President, AntiCancer Inc...
...Celltrion has recently completed successful clinical trials for its generics of Herceptin, Genentech’s anticancer drug, and of Remicade, Johnson & Johnson’s rheumatoid arthritis drug, to start selling them...
International Edition